Interesting MPC Put And Call Options For February 2021

Investors in Marathon Petroleum Corp. (Symbol: MPC) saw new options become available today, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MPC options chain for the new February 2021 contracts and identified one p Source: Industry Insights

MPC Crosses Above 6% Yield Territory

Looking at the universe of stocks we cover at Dividend Channel, in trading on Monday, shares of Marathon Petroleum Corp. (Symbol: MPC) were yielding above the 6% mark based on its quarterly dividend (annualized to $2.32), with the stock changing hands as low as $38.30 on the da Source: Industry Insights

Marathon St. Paul Park refinery workers authorize potential strike

Nearly 200 refinery workers represented by the International Brotherhood of Teamsters in St. Paul Park, Minnesota, voted last week to authorize a strike if they cannot reach an agreement with Marathon Petroleum on a new contract by the end of 2020, the union said on Thursday. Source: Industry Insights

Thursday Sector Laggards: Energy, Financial

Looking at the sectors faring worst as of midday Thursday, shares of Energy companies are underperforming other sectors, showing a 0.5% loss. Within that group, Marathon Petroleum Corp. (Symbol: MPC) and Pioneer Natural Resources Co (Symbol: PXD) are two of the day’s laggards, Source: Industry Insights

Energy Sector Update for 12/16/2020: BP, MPC, KNOP, XLE, USO, UNG

Energy stocks were higher in Wednesday’s pre-bell trading with the Energy Select Sector SPDR (XLE) recently climbing by 0.30%. The United States Oil Fund (USO) was down 0.09% and the United States Natural Gas Fund (UNG) was down 0.73%.Front-month West Texas Intermediate crude oil Source: Industry Insights

Monday's ETF Movers: XBI, IXC

In trading on Monday, the SPDR— S&P— Biotech ETF is outperforming other ETFs, up about 4.6% on the day. Components of that ETF showing particular strength include shares of Alexion Pharmaceuticals, up about 30.8% and shares of Syros Pharmaceuticals, up about 22 Source: Industry Insights